Reporting owner · CIK 0001824673

McNeill Jonathan

Visual SEC Form 4 history across 2 companies, 10 transactions and 2 filings.

PRESPresident and COOCRESCENT BIOPHARMA, INC.
Open-market mix
Latest filingSep 18, 2026, 08:01 PM
Filings2Form 4 records
Buying$00 purchases
Selling$606.4K6 sales
Net value−$606.4KBuys minus sells
Companies23 securities
Most recentSep 18, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-54Jan 242Sep 26

Net value flow

Buys minus sells

Jan 24
−$529.2K
Sep 26
−$77.2K

Transaction texture

Ownership and ticket size

Average P/S size$101.1K
Median P/S size$102.6K
Direct10
Indirect0
Sep 18, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern3Derivative Transactionfiling-context2Direct Ownershipfiling-context8Large Holdings Reductionholdings1Repeat Sellerpattern310b5-1 Detectedfiling-context8

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at CRESCENT BIOPHARMA, INC. on Sep 18, 2026 valued at $64,150.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at CRESCENT BIOPHARMA, INC. on Sep 18, 2026 valued at $64,150.

Review SEC filing

Associated companies

Visual map of known reporting history

CBIOCRESCENT BIOPHARMA, INC.2 transactions · latest Sep 18, 2026, 08:01 PMDYNDyne Therapeutics, Inc.8 transactions · latest Jan 04, 2024, 09:47 PM

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

McNeill Jonathan transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#225492CBIOMcNeill Jonathan
PRES
sale10b5-13.83k-$6.41MS09/1809/18
#225491CBIOMcNeill Jonathan
PRES
sale10b5-1731-$1.30MS09/1809/16
#200356DYNMcNeill Jonathan
CBO
exercise10b5-12.00k$0M01/04/202401/04/2024
#200355DYNMcNeill Jonathan
CBO
exercise10b5-117.9k$0M01/04/202401/03/2024
#200354DYNMcNeill Jonathan
CBO
sale10b5-12.00k-$3.62MS01/04/202401/04/2024
#200353DYNMcNeill Jonathan
CBO
exercise10b5-12.00k$146kM01/04/202401/04/2024
#200352DYNMcNeill Jonathan
CBO
sale10b5-110.3k-$19.6MS01/04/202401/03/2024
#200351DYNMcNeill Jonathan
CBO
sale10b5-17.69k-$14.1MS01/04/202401/03/2024
#200350DYNMcNeill Jonathan
CBO
exercise10b5-117.9k$1.31MM01/04/202401/03/2024
#200347DYNMcNeill Jonathan
CBO
sale10b5-111.9k-$15.5MS01/04/202401/02/2024

McNeill Jonathan Insider Activity FAQ

SEC Form 4 context

Who is McNeill Jonathan?

McNeill Jonathan is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001824673.

Which companies has McNeill Jonathan reported transactions for?

CRESCENT BIOPHARMA, INC., Dyne Therapeutics, Inc.

When was McNeill Jonathan's latest insider buy?

No open-market insider purchase is available for this period.

When was McNeill Jonathan's latest insider sale?

sale at CRESCENT BIOPHARMA, INC. on Sep 18, 2026 valued at $64,150.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.